Oxidative modification of low-density lipoprotein and atherogenetic risk in β-thalassemia

Blood

Volumn 92, Issue 10, 1998, Pages 3936-3942

  Livrea, M A ^a   Tesoriere, L ^b   Maggio, A ^b   D'Arpa, D ^b   Pintaudi, A M ^b   Pedone, E ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ATHEROGENESIS; BETA THALASSEMIA; CELL CULTURE; CLINICAL ARTICLE; CYTOTOXICITY; DISEASE ASSOCIATION; FEMALE; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0032533264     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3936.422k06_3936_3942     Document Type: Article

References (53)

1. Sonakul D, Suwanagool P, Sirivaidyapong P, Fucharoen S: Distribution of pulmonary thromboembolism lesions in thalassemic patients. Birth Defects 23:375, 1988
2. Wong V, Yu Y, Laing RHS, Tso WK, Li AMC, Chan TK: Cerebral thrombosis in β-thal/Hb E disease. Stroke 21:812, 1990
3. Pascher F, Keen R: Ulcer legs in Cooley's anemia. N Engl J Med 256:1220, 1957
4. Butthep P, Bunyaratvej A, Funuhara Y, Kitaguchi H, Fucharoen S, Sato S, Bhamarapravati N: Alterations in vascular endothelial cell-related plasma proteins in thalassaemic patients and their correlation with clinical symptoms. Thromb Haemost 74:1045, 1995
5. Steinberg D, Parthasaraty S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol. Modification of low density lipoprotein that increase atherogenicity. N Engl J Med 320:915, 1989
6. Berliner JA, Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20:707, 1996
7. Schawartz CJ, Valente AJ: The pathogenesis of atherosclerosis, in Frei B (ed): Natural Antioxidants in Human Health und Disease. New York, NY, Academic, 1994, p 287
8. Morel D, DiCorleto P, Chisolm G: Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4:357, 1984
9. Steinbrecher U, Parthasarathy S, Leake D, Witztum J, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883, 1984
10. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D: Decrease of reactive amino groups during oxidation or endothelial cell modification of LDL: Correlation with changes in receptor-mediated metabolism. Arteriosclerosis 7:135, .1987
11. Jacobs A: The pathology of iron overload, in Jacobs A, WorwoodM(eds): Iron in Biochemistry and Medicine II. New York, NY, Academic, 1980, p 427
12. Paganga G, Rice-Evans C, Rule R, Leake D: The interaction between ruptured erythrocytes and low density lipoproteins. FEBS 303:154, 1992
13. Giardini O, Cantani A, Donfrancesco A, Martine F, Mannarino O, D'Eufemia P, Miano C, Ruberto U, Lubrano R: Biochemical and clinical effects of vitamin E administration in homozigous beta-thalassemia. Acta Vitaminol Enzymol 7:55, 1985
14. Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben H-J, D'Arpa D, D'Anna R, Bongiorno A: Oxidative stress and antioxidant status in β-thalassemia major: Iron overload and depletion of lipid soluble antioxidants. Blood 88:3608, 1996
15. Tesoriere L, D'Arpa D, Maggio A, Giaccone V, Pedone E: Oxidation resistance of LDL is correlated with vitamin E status in β-thalassemia intermedia. Atherosclerosis 137:429, 1998
16. Parthasarathy S, Barnett J, Fong LG: High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta 1044:275, 1990
17. Chisolm GM: Cytotoxicity of oxidized lipoproteins. Curr Opin Lipidol 2:311, 1991
18. Gotoh N, Graham A, Niki E, Darley-Usmar VM: Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages. Biochem J 296:151, 1993
19. Kosugi K, Morel DW, DiCorleto PE, Chisolm GM: Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle. J Cell Physiol 130:311, 1987
20. Friedwald WT, Levy RI, Fredrickson DS: Estimation of the concentration of LDL-cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499, 1972
21. Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH, Demaker PNM: Improved measurement of low density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein. Clin Chem 38:2066, 1992
22. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G: Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53:3145, 1991
23. Bradford MM: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1976
24. Buege JA, Aust SD: Microsomal lipid peroxidation, in Fleischer S, Packer L (eds): Methods Enzymol (vol 52). New York, NY, Academic, 1978, p 302
25. Pryor WA, Castle L: Chemical methods for detection of lipid hydroperoxides, in Packer L (ed): Methods Enzymol (vol 105). Orlando, FL, Academic, 1984, p 293
26. Kraft NE: Carotenoid reversed-phase high performance liquid Chromatography methods: Reference compendium, in Packer L (ed): Methods in Enzymol (vol 213). San Diego, CA, Academic, 1992, p 185
27. Maioli M, Cuccuru GB, Pranzetti P, Pacifico A, Cherchi GM: Plasma lipids and lipoprotein pattern in beta-thalassemia major. Acta Haematol 71:106, 1984
28. Maioli M, Pettinato S, Cherchi GM, Giraudi D, Pacifico A, Pupita G, Tidore MGB: Plasma lipids in beta-thalassemia minor. Atherosclerosis 75:245, 1989
29. Morel DW, Hessler JR, Chisolm GM: Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipids. J Lipid Res 24:1070, 1983
30. Hughes H, Mathews B, Lenz ML, Guyton JR: Cytotoxicity of oxidized LDL to porcine aortic smooth cells is associated with oxisterols 7-chetosterol and 7-hydroxycholesterol. Arterioscler Thromb 14:1177, 1994
31. Chiu DT-Y, Van den Berg J, Kuypers FA, Hung I-J, Wei J-S, Liu T-Z: Correlation of membrane lipid peroxidation with oxidation of hemoglobin variants: Possibly related to the rates of hemin release. Free Radic Biol Med 21:89, 1996
32. Van Dyke BR, Saltman P: Hemoglobin: A mechanism for the generation of hydroxyl radicals. Free Radic Biol Med 20:985, 1996
33. Grinberg LN, Rachmilewitz EA, Kitrossky N, Chevion M: Hydroxyl radical generation in β-thalassemic red blood cells. Free Radic Biol Med 18:611, 1995
34. Scott MD, Van den Berg JJM, Repka T, Rouyer-Fessard Ph, Hebbel RP, Beuzard Y, Lubin B: Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemic erythrocytes. J Clin Invest 91:1706, 1993
35. Yagi K: Lipid peroxides and human disease. Chem Phys Lipids 45:337, 1987
36. Esterbauer H, Gebieki J, Puhl H, Jurgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radie Biol Med 13:341, 1992
37. Rangaswamy S, Penn MS, Saidel GM, Chisolm GM: Exogenous oxidized low-density iipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ Res 80:37, 1997
38. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P: Plasma MDA as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem 43:1209, 1997
39. Liu P, Olivieri N: Iron overload cardiomyopathies: New insights into an old disease. Cardiovasc Drugs 8:101, 1994
40. Gillum RF: Body iron stores and atherosclerosis. Circulation 96:3261, 1997
41. Salonen JT: Role of iron as cardiovascular risk factor. Curr Opin Lipidol 4:277, 1993
42. Sullivan JL: Iron and sex difference in heart disease. Lancet 1:1293, 1981
43. Sullivan JL: The iron paradigm of ischemic heart disease. Am Heart J 117:1177, 1989
44. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F: Body iron stores and the risk of carotid atherosclerosis. Prospective results from the Bruneck study. Circulation 96:3300, 1997
45. Halle M, Konig D, Berg A, Keul J, Baumstark KMW: Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. Atherosclerosis 128:235, 1997
46. Smith LH: Overview of hemochromatosis. West J Med 153:296, 1990
47. Altamentova SM, Marva E, Shaklai N: Oxidative interaction of unpaired hemoglobin chains with lipids and proteins: A key for modified serum lipoproteins in thalassemia. Arch Biochem Biophys 345:39, 1997
48. Maggi E. Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, Gazo A, Nai M, Romanini D, Bellomo G: Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 45:876, 1994
49. Loughrey CM, Young IS, McEneny J, McDowell IFW, McMaster C, McNamee PT, Trimble ER: Oxidation of low density lipoprotein in patients on regular hemodialysis. Atherosclerosis 110:185, 1994
50. Giovanetti S, Balesti PL, Cioni L: Spontaneous in vitro auto hemolysis of blood from chronic uremic patients. Clin Sci 29:407, 1965
51. Vanella A, Geremia E, Pinturo R, Tiriolo P, Liuzzo G, Tiriolo C, Custorella A, Condorelli G, Giglio A: Superoxide dismutase activity and reduced glutathione content in erythrocyte of uremic patients on chronic dialysis. Acta Haematol 70:312, 1983
52. Monnet PD, Kane F, Konan-Waidhet D, Akpona S, Kora J, Diafouka F, Sess D, Sangare A, Yapo AE: Evaluation of atherogenic risk in homozygous sickle cell disease: Study of lipid and apolipoprotein AI and B plasma levels. Bull Soc Pathol Exot 89:278, 1996
53. Djoumessi S, Zekeng L, Lando G, Zeukeng D: Serum lipids and atherogenic risk in sickle cell trait carriers. Ann Biol Clin 52:663, 1994